Leaflet NIASPAN 750mg prolonged-release tablets


Indicated for: dyslipidemia

Route of administration: oral

Substance: nicotinic acid (lipid-lowering agent)

ATC: C10AD02 (Cardiovascular system | Lipid modifying agents, plain | Nicotinic acid and derivatives)

Nicotinic acid, also known as niacin, is a B-complex vitamin (vitamin B3) used to treat dyslipidemia and reduce the risk of cardiovascular diseases. It helps lower LDL cholesterol and triglycerides while increasing HDL cholesterol.

It is commonly used in patients at high risk of cardiovascular diseases, especially when other medications are not tolerated or effective. Nicotinic acid is available in oral tablet form.

Side effects may include skin flushing, itching, nausea, or stomach discomfort. These reactions can be reduced by taking the medication after meals or using extended-release formulations.

Patients should inform their doctor about any liver conditions or diabetes before use. Periodic monitoring of liver function is recommended during treatment.

General data about NIASPAN 750mg

  • Substance: nicotinic acid
  • Date of last drug list: 01-07-2013
  • Commercial code: W53493003
  • Concentration: 750mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 56
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for nicotinic acid

  • 1000mg
  • 375mg
  • 500mg
  • 750mg

Combinations with other substances